Serum cytokines in follicular lymphoma
نویسندگان
چکیده
منابع مشابه
Serum cytokines in follicular lymphoma
the core spliceosome? How is RBM15’s association with specific genes regulated? What is the dominant-negative mechanism by which Mpl-TR acts to decrease HSC maintenance? Answers to these questions not only will elucidate critical aspects of the splicing machinery, but will be relevant for our understanding of the role of the RBM15-MKL1 fusion protein in AMKL. Conflict-of-interest disclosure: Th...
متن کاملSerum cytokines in follicular lymphoma
the core spliceosome? How is RBM15’s association with specific genes regulated? What is the dominant-negative mechanism by which Mpl-TR acts to decrease HSC maintenance? Answers to these questions not only will elucidate critical aspects of the splicing machinery, but will be relevant for our understanding of the role of the RBM15-MKL1 fusion protein in AMKL. Conflict-of-interest disclosure: Th...
متن کاملSerum cytokines in follicular lymphoma.
the core spliceosome? How is RBM15’s association with specific genes regulated? What is the dominant-negative mechanism by which Mpl-TR acts to decrease HSC maintenance? Answers to these questions not only will elucidate critical aspects of the splicing machinery, but will be relevant for our understanding of the role of the RBM15-MKL1 fusion protein in AMKL. Conflict-of-interest disclosure: Th...
متن کاملPrognostic significance of pretreatment serum cytokines in classical Hodgkin lymphoma.
PURPOSE Although the International Prognostic Score (IPS) is the gold standard for risk-stratifying patients with classical Hodgkin lymphoma (cHL), these criteria do not accurately predict outcome. As cytokines are critically involved in driving cHL, we tested whether pretreatment serum cytokine levels could provide additional prognostic information. EXPERIMENTAL DESIGN Thirty cytokines were ...
متن کاملPrognostic serum cytokines in classical Hodgkin lymphoma--letter.
We read with interest the study by Marri and colleagues (1) suggesting that in patients with classical Hodgkin lymphoma (cHL), the pretreatment cytokine profile, particularly serum levels of IL6 and IL2R, may be used to identify those at high risk for early-disease relapse. The authors further suggest that targeting the cross-talk between Hodgkin–Reed/Sternberg cells and reactive stromal cells ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2015
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood-2014-12-615302